MedTrace Logo

Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye

NCT03183089 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-06-09

No results posted yet for this study

Summary

The objective of this study is to evaluate the efficacy of Rohto Dry-Aid® in comparison to Systane® Ultra on visual function and tear film stability in patients diagnosed with Dry Eye.

Conditions

  • Dry Eye Syndromes
  • Dry Eye

Interventions

DRUG

Rohto Dry-Aid®

DRUG

Systane® Ultra

Sponsors & Collaborators

  • The Mentholatum Company

    lead INDUSTRY

Principal Investigators

  • Gail L Torkildsen, M.D. · Andover Eye Associates

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-03
Primary Completion
2016-01-04
Completion
2016-01-04
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03183089 on ClinicalTrials.gov